Sep 29, 2021 / 03:55PM GMT
Brent Salva - Benzinga - Head of Newsdesk
Let's go with our next presentation. I see he's behind [the stage]. He's ready to go. Lantern Pharma. That's ticker LTRN. And we have joining us from Lantern, Panna Sharma, CEO and President. And there he is. How is it going?
Panna Sharma - Lantern Pharma Inc. - CEO, President, & Director
Great. Thanks for having me on.
Brent Salva - Benzinga - Head of Newsdesk
No problem. It is our pleasure. I'll let you have the floor, sir.
Panna Sharma - Lantern Pharma Inc. - CEO, President, & Director
Great. Thank you. Lantern, we're publicly traded on NASDAQ, ticker LTRN, and we're one of the handful of companies that is at the forefront of using big data and artificial intelligence to help accelerate the pace and lower the cost of drug development, specifically in oncology. I think everyone knows that developing oncology medicines takes a lot of time, takes a lot of capital, and historically has been fairly inefficient because the
Lantern Pharma Inc. at Benzinga Healthcare Small Cap Conference (Virtual) Transcript
Sep 29, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers